Patient Guide: Expanded Access to Telisotuzumab Vedotin

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04830202
Status: AVAILABLE
Condition: Non-Small Cell Lung Cancer (NSCLC)
Phase: Research Study

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Sacramento, California
  • • Mountain Lakes, New Jersey
  • • West Perth, Western Australia
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Expanded Access to Telisotuzumab Vedotin - Join Clinical Trial NCTNCT04830202

How to Join This Clinical Trial - NCTNCT04830202

Learn how to participate in this clinical trial studying an investigational therapy for Non-Small Cell Lung Cancer (NSCLC). Current status: AVAILABLE.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
AVAILABLE
Study Identifier
NCTNCT04830202 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Sacramento, California 95816 - United States

Status: AVAILABLE

Clinical Research Site

Mountain Lakes, New Jersey 07046-1743 - United States

Status: AVAILABLE

Clinical Research Site

West Perth, Western Australia 6005 - Australia

Status: AVAILABLE

Clinical Research Site

Cologne, 50937 - Germany

Status: AVAILABLE

Clinical Research Site

Gauting, 82131 - Germany

Status: AVAILABLE

Clinical Research Site

Yau Ma Tei, - Hong Kong

Status: AVAILABLE

Clinical Research Site

Ramat Gan, Tel-Aviv 5265601 - Israel

Status: AVAILABLE

Clinical Research Site

Jerusalem, 91031 - Israel

Status: AVAILABLE

Clinical Research Site

Petakh Tikva, 4941492 - Israel

Status: AVAILABLE

How to Enroll in This Study

To learn more about participating in this clinical trial for Non-Small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships